HealthQuill France
Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9% vaccination success rate.
Drugs Medical Pharma

France’s Valneva says trial vaccine for chikungunya post 98.9% rate

HQ Team June 13, 2023: Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9%.

Read More
Seven newborns have died in France due to severe neonatal sepsis associated with enterovirus during the more than one-year period starting July 2022, the WHO stated.
Drugs Health Medical Pharma

France reports a rapid rise in severe neonatal sepsis since July 2022

HQ Team June 1, 2023: Seven newborns have died in France due to severe neonatal sepsis associated with enterovirus during the more than.

Read More